NCT02932722View on ClinicalTrials.gov

Effect of Propofol on Cardioprotective Role of Remote Ischemic Preconditioning (RIPC)

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

February 7, 2018

Study Completion Date

February 7, 2018

Conditions
Myocardial Infarction
Interventions
OTHER

Control

Patients in the control groups do not receive any anesthetic during remote ischemic preconditioning.

DRUG

Propofol

Patients in the propofol group receive propofol anesthesia during remote ischemic preconditioning.

DRUG

Sevoflurane

Patients in the sevoflurane group receive sevoflurane anesthesia during remote ischemic preconditioning.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02932722 - Effect of Propofol on Cardioprotective Role of Remote Ischemic Preconditioning (RIPC) | Biotech Hunter | Biotech Hunter